Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 6, 2001, Pages 881-885

  Valtonen, Matti ^a   Tiula, Eero ^a   Takkunen, Olli ^a   Backman, Janne T ^b   Neuvonen, Pertti J ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; PENICILLANIC ACID; PENICILLIN DERIVATIVE; PIPERACILLIN; TAZOBACTAM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; MALE; METABOLISM; METHODOLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBIOTICS, COMBINED; COMPARATIVE STUDY; ENZYME INHIBITORS; FEMALE; HEMODIAFILTRATION; HEMOFILTRATION; HUMAN; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGE; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; SUPPORT, NON-U.S. GOV'T;

EID: 0035654136     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.6.881     Document Type: Article

References (12)

1. Sanders, W. E., Jr & Sanders, C. C. (1996). Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clinical Infectious Diseases 22, 107-23.
2. Sörgel, F. & Kinzig, M. (1993). The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy 31, Suppl. A, 39-60.
3. Johnson, C. A., Halstenson, C. E., Kelloway, J. S., Shapiro, B. E., Zimmerman, S. W., Tonelli, A. et al. (1992). Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clinical Pharmacological Therapy 51, 32-41.
4. Van der Werf, T. S., Mulder, P. O. M., Zijlstra, J. G., Uges, D. R. A. & Stegeman, C. A. (1997). Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH). Intensive Care Medicine 23, 873-7.
5. Ocampo, A. P., Hoyt, K. D., Wadgaonkar, N., Carver, A. H. & Puglisi, C. V. (1989). Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high performance liquid chromatography. Journal of Chromatography 496, 167-79.
6. Valtonen, M., Tiula, E. & Neuvonen, P. J. (1997). Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure. Journal of Antimicrobial Chemotherapy 40, 695-700.
7. Valtonen, M., Tiula, E., Backman, J. T. & Neuvonen, P. J. (2000). Elimination of meropenem during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure. Journal of Antimicrobial Chemotherapy 45, 701-4.
8. Joos, B., Schmidli, M. & Keusch, G. (1996). Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. Nephrology, Dialysis and Transplantation 11, 1582-5.
9. Capellier, G., Cornette, C., Boillot, A., Guinhard, C., Jacques, T., Blasco, G. et al. (1998). Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration. Critical Care Medicine 26, 88-91.
10. Keller, E., Böhler, J., Busse-Grawitz, A., Reetze-Bonorden, P., Krumme, B. & Schollmeyer, P. (1995). Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients. Clinical Nephrology 43, Suppl. 1, 20-2.
11. MacGowan, A. P. & Wise, R. (2001). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. Journal of Antimicrobial Chemotherapy 48, Suppl. 1, 17-28.
12. Craig, W. A. & Ebert, S. C. (1992). Continuous infusion of β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 36, 2577-83.